0001193125-14-350092.txt : 20140923 0001193125-14-350092.hdr.sgml : 20140923 20140923160801 ACCESSION NUMBER: 0001193125-14-350092 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20140923 DATE AS OF CHANGE: 20140923 GROUP MEMBERS: PS MANAGEMENT GP, LLC GROUP MEMBERS: WILLIAM A. ACKMAN SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ALLERGAN INC CENTRAL INDEX KEY: 0000850693 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 951622442 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-40724 FILM NUMBER: 141116161 BUSINESS ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 7142464500 MAIL ADDRESS: STREET 1: P.O. BOX 19534 CITY: IRVINE STATE: CA ZIP: 92713-9534 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Pershing Square Capital Management, L.P. CENTRAL INDEX KEY: 0001336528 IRS NUMBER: 383694136 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 42ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-813-3700 MAIL ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 42ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 SC 13D/A 1 d793817dsc13da.htm AMENDMENT NO.12 TO SCHEDULE 13D Amendment No.12 to Schedule 13D

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Amendment No. 12

ALLERGAN, INC.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

018490102

(CUSIP Number)

Roy J. Katzovicz, Esq.

Pershing Square Capital Management, L.P.

888 Seventh Avenue, 42nd Floor

New York, New York 10019

212-813-3700

with a copy to:

Stephen Fraidin, Esq.

Richard M. Brand, Esq.

Kirkland & Ellis LLP

601 Lexington Avenue

New York, NY 10022

212-446-4800

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

September 23, 2014

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box.  ¨

Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes)

CUSIP NO. 018490102    13D    Page 2

 

  1   

NAME OF REPORTING PERSON

 

Pershing Square Capital Management, L.P.

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a)  x        (b)  ¨

 

  3  

SEC USE ONLY

 

  4  

SOURCE OF FUNDS (SEE INSTRUCTIONS)

 

OO (See Item 3)

  5  

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

¨

  6  

CITIZENSHIP OR PLACE OR ORGANIZATION

 

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

      7    

SOLE VOTING POWER

 

NONE

     8   

SHARED VOTING POWER

 

28,878,538

     9   

SOLE DISPOSITIVE POWER

 

NONE

   10   

SHARED DISPOSITIVE POWER

 

28,878,538

11  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

 

28,878,638

12  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

¨

13  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

9.7%1

14  

TYPE OF REPORTING PERSON

 

IA

 

1 Calculated based on 297,183,809 shares of common stock, $0.01 par value, of Allergan, Inc., outstanding as of July 31, 2014, as reported in Allergan, Inc.’s Quarterly Report on Form 10-Q for the period ended June 30, 2014, as filed with the Securities and Exchange Commission on August 5, 2014.

CUSIP NO. 018490102    13D    Page 3

 

  1   

NAME OF REPORTING PERSON

 

PS Management GP, LLC

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a)  x        (b)  ¨

 

  3  

SEC USE ONLY

 

  4  

SOURCE OF FUNDS (SEE INSTRUCTIONS)

 

OO (See Item 3)

  5  

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

¨

  6  

CITIZENSHIP OR PLACE OR ORGANIZATION

 

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

      7    

SOLE VOTING POWER

 

NONE

     8   

SHARED VOTING POWER

 

28,878,538

     9   

SOLE DISPOSITIVE POWER

 

NONE

   10   

SHARED DISPOSITIVE POWER

 

28,878,538

11  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

 

28,878,638

12  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

¨

13  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

9.7%2

14  

TYPE OF REPORTING PERSON

 

OO

 

2 Calculated based on 297,183,809 shares of common stock, $0.01 par value, of Allergan, Inc., outstanding as of July 31, 2014, as reported in Allergan, Inc.’s Quarterly Report on Form 10-Q for the period ended June 30, 2014, as filed with the Securities and Exchange Commission on August 5, 2014.

CUSIP NO. 018490102    13D    Page 4

 

  1   

NAME OF REPORTING PERSON

 

William A. Ackman

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a)  x        (b)  ¨

 

  3  

SEC USE ONLY

 

  4  

SOURCE OF FUNDS (SEE INSTRUCTIONS)

 

OO (See Item 3)

  5  

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

¨

  6  

CITIZENSHIP OR PLACE OR ORGANIZATION

 

United States

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

      7    

SOLE VOTING POWER

 

NONE

     8   

SHARED VOTING POWER

 

28,878,538

     9   

SOLE DISPOSITIVE POWER

 

NONE

   10   

SHARED DISPOSITIVE POWER

 

28,878,538

11  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

 

28,878,638

12  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

¨

13  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

9.7%3

14  

TYPE OF REPORTING PERSON

 

IN

 

3 Calculated based on 297,183,809 shares of common stock, $0.01 par value, of Allergan, Inc., outstanding as of July 31, 2014, as reported in Allergan, Inc.’s Quarterly Report on Form 10-Q for the period ended June 30, 2014, as filed with the Securities and Exchange Commission on August 5, 2014.

CUSIP NO. 018490102    13D    Page 5

 

  Item 1. Security and Issuer

This amendment No. 12 to Schedule 13D (this “Amendment No. 12”), which amends and supplements the statement on Schedule 13D filed on April 21, 2014 (the “Original 13D”), as amended and supplemented by amendment No. 1 (“Amendment No. 1”), filed on May 2, 2014, amendment No. 2 (“Amendment No. 2”), filed on May 5, 2014, amendment No. 3 (“Amendment No. 3”), filed on May 12, 2014, amendment No. 4 (“Amendment No. 4”), filed on May 19, 2014, amendment No. 5 (“Amendment No. 5”), filed on May 21, 2014, amendment No. 6 (“Amendment No. 6”), filed on June 2, 2014, amendment No. 7 (“Amendment No. 7”), filed on June 13, 2014, amendment No. 8 (“Amendment No. 8”), filed on June 30, 2014, amendment No. 9 (“Amendment No. 9”), filed on July 17, 2014, amendment No. 10 (“Amendment No. 10”), filed on August 6, 2014, and amendment No. 11 (“Amendment No. 11”), filed on September 9, 2014 (the Original 13D as amended and supplemented by Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, Amendment No. 6, Amendment No. 7, Amendment No. 8, Amendment No. 9, Amendment No. 10, Amendment No. 11 and this Amendment No. 12, the “Schedule 13D”), by (i) Pershing Square Capital Management, L.P., a Delaware limited partnership (“Pershing Square”); (ii) PS Management GP, LLC, a Delaware limited liability company (“PS Management”) and (iii) William A. Ackman, a citizen of the United States (together with Pershing Square and PS Management, the “Reporting Persons”) relates to the common stock, par value $0.01 per share (the “Common Stock”), of Allergan, Inc., a Delaware corporation (the “Issuer”). The principal executive offices of the Issuer are located at: 2525 Dupont Drive, Irvine, California, 92612.

Capitalized terms not defined in this Amendment No. 12 shall have the meaning ascribed to them in the Schedule 13D. Except as set forth herein, the Schedule 13D is unmodified.

 

  Item 4. Purpose of Transaction

Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following information:

On September 23, 2014, Pershing Square sent a letter to the board of directors of the Issuer. The letter is attached as Exhibit 99.38 and is incorporated herein by reference.

 

  Item 7. Material to be Filed as Exhibits.

 

Exhibit 99.38    Letter to Allergan, Inc. Board of Directors from Pershing Square Capital Management, L.P., dated as of September 23, 2014.

CUSIP NO. 018490102    13D    Page 6

 

SIGNATURES

After reasonable inquiry and to the best of each of the undersigned’s knowledge and belief, each of the undersigned certify that the information set forth in this statement is true, complete and correct.

 

Date: September 23, 2014     PERSHING SQUARE CAPITAL MANAGEMENT, L.P.
    By:   PS Management GP, LLC, its General Partner
    By:  

/s/ William A. Ackman

      William A. Ackman
      Managing Member

 

PS MANAGEMENT GP, LLC
By:  

/s/ William A. Ackman

  William A. Ackman
  Managing Member
 

/s/ William A. Ackman

  William A. Ackman

CUSIP NO. 018490102    13D    Page 7

 

EXHIBIT INDEX

 

Exhibit

   

Description

Exhibit 99.1    Joint Filing Agreement, dated as of April 21, 2014, among Pershing Square Capital Management, L.P., PS Management GP, LLC and William A. Ackman.*
Exhibit 99.2    Trading data.*
Exhibit 99.3    Letter Agreement, dated as of February 25, 2014, among Pershing Square Capital Management, L.P. and Valeant Pharmaceuticals International, Inc.*
Exhibit 99.4    Amended and Restated Limited Liability Company Agreement of PS Fund 1, LLC, dated as of April 3, 2014, by and among Pershing Square Capital Management, L.P., Pershing Square L.P., Pershing Square II, L.P., Pershing Square International, Ltd., Pershing Square Holdings, Ltd., and Valeant Pharmaceuticals International.*
Exhibit 99.5    Letter to Michael R. Gallagher from Pershing Square Capital Management, L.P., dated as of May 5, 2014.*
Exhibit 99.7    Letter to Allergan, Inc. Board of Directors from Pershing Square Capital Management, L.P., dated as of May 19, 2014.*
Exhibit 99.8    Letter to Allergan, Inc. Board of Directors from Pershing Square Capital Management, L.P., dated as of May 21, 2014.*
Exhibit 99.9    Letter Agreement, dated as of May 30, 2014, between Pershing Square Capital Management, L.P. and Valeant Pharmaceuticals International, Inc.*
Exhibit 99.10    Press Release, dated June 13, 2014.*
Exhibit 99.11    Press Release, dated June 27, 2014.*
Exhibit 99.12    Stipulation and Order Regarding Application of Allergan Rights Plan and Dismissal Without Prejudice, dated June 28, 2014.*
Exhibit 99.13    Letter to Allergan, Inc. Board of Directors from Pershing Square Capital Management, L.P., dated as of July 16, 2014.*
Exhibit 99.14    Form of Share Call Option Master Confirmation and Form of Amendment to Share Call Option Master Confirmation.*
Exhibit 99.15    Form of Share Forward Master Confirmation.*
Exhibit 99.16    Letter Agreement, executed July 15, 2014, between Pershing Square Capital Management, L.P. and Valeant Pharmaceuticals, Inc.*
Exhibit 99.17    Share Call Option Master Confirmation, by and among PS Fund 1 and Nomura International plc, dated as of February 27, 2014, and Amendment to Share Call Option Master Confirmation, by and among PS Fund 1 and Nomura International plc, dated as of April 17, 2014.*
Exhibit 99.18    Share Call Option Supplemental Confirmation, by and among PS Fund 1 and Nomura International plc, dated as of March 3, 2014.*

CUSIP NO. 018490102    13D    Page 8

 

Exhibit 99.19    Share Call Option Supplemental Confirmation, by and among PS Fund 1 and Nomura International plc, dated as of March 6, 2014.*
Exhibit 99.20    Share Call Option Supplemental Confirmation, by and among PS Fund 1 and Nomura International plc, dated as of March 11, 2014.*
Exhibit 99.21    Share Call Option Supplemental Confirmation, by and among PS Fund 1 and Nomura International plc, dated as of March 14, 2014.*
Exhibit 99.22    Share Call Option Supplemental Confirmation, by and among PS Fund 1 and Nomura International plc, dated as of March 19, 2014.*
Exhibit 99.23    Share Call Option Supplemental Confirmation, by and among PS Fund 1 and Nomura International plc, dated as of March 24, 2014.*
Exhibit 99.24    Share Call Option Supplemental Confirmation, by and among PS Fund 1 and Nomura International plc, dated as of March 27, 2014.*
Exhibit 99.25    Share Call Option Supplemental Confirmation, by and among PS Fund 1 and Nomura International plc, dated as of April 1, 2014.*
Exhibit 99.26    Share Call Option Supplemental Confirmation, by and among PS Fund 1 and Nomura International plc, dated as of April 4, 2014.*
Exhibit 99.27    Share Call Option Supplemental Confirmation, by and among PS Fund 1 and Nomura International plc, dated as of April 8, 2014.*
Exhibit 99.28    Share Call Option Supplemental Confirmation, by and among PS Fund 1 and Nomura International plc, dated as of April 11, 2014.*
Exhibit 99.29    Share Call Option Supplemental Confirmation, by and among PS Fund 1 and Nomura International plc, dated as of April 14, 2014.*
Exhibit 99.30    Share Call Option Supplemental Confirmation, by and among PS Fund 1 and Nomura International plc, dated as of April 15, 2014.*
Exhibit 99.31    Share Call Option Supplemental Confirmation, by and among PS Fund 1 and Nomura International plc, dated as of April 16, 2014.*
Exhibit 99.32    Share Call Option Supplemental Confirmation, by and among PS Fund 1 and Nomura International plc, dated as of April 17, 2014.*
Exhibit 99.33    Share Forward Master Confirmation, by and among PS Fund 1 and Nomura International plc, dated as of April 21, 2014.*
Exhibit 99.34    Share Forward Supplemental Confirmation, by and among PS Fund 1 and Nomura International plc, dated as of April 21, 2014.*
Exhibit 99.35    Guarantee, by and among Pershing Square, L.P., Pershing Square II, L.P., Pershing Square International, Ltd., and Pershing Square Holdings, Ltd. and Nomura International plc, dated as of April 17, 2014.*
Exhibit 99.36    Confidentiality Agreement, by and among Pershing Square Capital Management, L.P. and Valeant Pharmaceuticals International, Inc., dated as of February 9, 2014, and Amended and Restated Confidentiality Agreement, by and among Pershing Square Capital Management, L.P. and Valeant Pharmaceuticals International, Inc., dated as of February 20, 2014.*

CUSIP NO. 018490102    13D    Page 9

 

Exhibit 99.37    Letter to Allergan, Inc. Board of Directors from Pershing Square Capital Management, L.P., dated as of September 9, 2014.*
Exhibit 99.38    Letter to Allergan, Inc. Board of Directors from Pershing Square Capital Management, L.P., dated as of September 23, 2014.

 

* Previously Filed
EX-99.38 2 d793817dex9938.htm EX-99.38 EX-99.38

Exhibit 99.38

 

LOGO

September 23, 2014

Mr. David E. I. Pyott,

Mr. Michael R. Gallagher

Mr. Russell T. Ray

Dr. Trevor Mervyn Jones

Mr. Louis J. Lavigne

Dr. Deborah Dunsire

Dr. Peter J. McDonnell

Mr. Timothy D. Proctor

Mr. Henri A. Termeerstev murr

To the Board of Directors of Allergan:

We have read published reports that you are negotiating a substantial highly leveraged acquisition that would not require shareholder approval in an attempt to preclude a transaction with Valeant. This action would directly contradict your repeated published statements that: “While Allergan does not believe that Valeant’s offer provides compelling value relative to the alternatives available to the Company, the Allergan Board of Directors fully supports the right of shareholders to vote on the value proposition offered by Valeant at the appropriate time.”

By undertaking an acquisition without a shareholder vote, with the purpose and desired effect of frustrating a Valeant transaction, you are breaching your commitment that shareholders would have a vote on the value proposition offered by Valeant. We do not believe you can lawfully undertake such a transaction, particularly given your failure to engage with Valeant.

If you take such action we will immediately bring litigation against you (and any counterparty that aids and abets you) for breach of fiduciary duty.

 

PERSHING SQUARE CAPITAL MANAGEMENT, L.P.
Sincerely,
LOGO
William A. Ackman
Chief Executive Officer
 GRAPHIC 3 g793817ex99_38img1.jpg GRAPHIC begin 644 g793817ex99_38img1.jpg M_]C_X0`817AI9@``24DJ``@``````````````/_L`!%$=6-K>0`!``0```!D M``#_X01.:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@ M8F5G:6X](N^[OR(@:60](EG)E4WI.5&-Z:V,Y9"(_/B`\ M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)! M9&]B92!835`@0V]R92`U+C4M8S`R,2`W.2XQ-30Y,3$L(#(P,3,O,3`O,CDM M,3$Z-#&UL;G,Z9&,](FAT='`Z+R]P=7)L+F]R M9R]D8R]E;&5M96YT&UL;G,Z&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B('AM<#I##PO'!A8VME="!E;F0](G(B/S[_[0!(4&AO=&]S:&]P(#,N,``X M0DE-!`0```````\<`5H``QLE1QP"```"``(`.$))300E```````0_.$?B4(ZNB(GGNM=AARJZU5G=A$>=BV#QL)G*4QMK7+6 M//5ZM%VEDFG/X^>O\2E@W\_(G.] MD)0LKZ577AJ_/733AOQS5AY>+FFI7T/(,I2/4%4B+V.M@E&`,`8 M`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@# M`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,` M8`P!@#`&`,`8`P!@#`&`,`8`P!@'$W/'I]_K_#,--K1T9K+JTZ>9;]@LT+5V M99&PRT?"QYGD?'$>R3E%J@I(2SYO&Q;%,ZJA`.\D7[M-%!(OD=50X%*`CZ96 MNY"LZ3UX?,SPT6]EP?@4BF+6SW/&C;F];?6NKY? MZG'[Y.W&YCRI+H5V+;KHO%KCX+P?,V&6VM0VSJ#+UIQ-3*5=ND*=DM,4>PN8 M:4=P4JD!UE8&TPJQ'D<$FP5$H.V*Q%BIJ"9%0AO$X7;=JUD8SLITQY+1]5'K MOJO&IUKMBUG8\['5_P!M./U1E1O15HT:@?IW5;<_4/M?NKZ=]?O8]@.G&L=> MQ>W-5WJQ2[F2VEU<>WJR+IQ/5K8TRJ@JWNR;]E\W-P+E1<)5I%$#YLHE60$> M7A6Y8V7/$M7?JIJCSW;;65@Y,\&-Q3PXT:5*N._'_`*N* MI2NJIJC>'R;T^'^OYYV]#TNA4.?MS!A^!7`&`,`8`P!@#`&`,`8`P!@#`&`, M`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P! M@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&` M,`XF-X@(\"/'W9E*H6KH?"ZDF3(B2CURW9$54!,AWCA!L0R@@(E3*990A3JF M`.?$.1XR.]-6HU;25:5>VIBX_::3:ISV7YF+?:#JGICN/2$*9M%:?!**>-[# M1[-2;M+5FRZ\OD6NW?U?9%0?0L@1DA=ZE*LTG,:[<)."H&`Q?`Q%#E-3NSP[ MWIG<@W31IZ)\#E=P[=V_N#7NRU6JDI:5W3I77X\-C$VA;#FGKJ9^G;]2>`JF MPY;8\!,U76.WY6NM6VG.Z^O`9*@^B)",5`8BF]A86+*!YZL>X`._;_4X@3MQ M.FUK7+ M=*M[FTS0_7W576BD(Z\U'5RU^"4?N9B7>O)&1G[3;[/(F]V7M]YM\Z[D+'AC8T+"?0HIM:TW=.;XG;Q,#'Q(M6:MO=MU;IQ M?-ZF!5>^IA.S$!L_L`ZZX3$5THU9M.^:MG=]'V'"N[O\MK*ZR&OKYM[_``TW MA@=$U#7;9&.$UG))=67%BBH]*Q%$G`U+?<[=RRK\(3=OW''AI1TKOLU%>=Z;LN+"E:TU MY!.IZQSKOS<'!%!,YDF,='MRJ/)26?*%!-NV0*9150P```'(AB M;T(+V1:LV7>Y85;C;MRI24777AM7Q37P-#ND_I:=#:GM6/Z<=O]6;!UKOEVS=KZ2W+ MKSL?V'I&I^WU3ADRBYE:8U/LUPPI^YH5CXJ6.F&4,JF8#O8X5V)O]GSF+VG% ML-X>9UK6JFW12Y).F_AQ//8O9.WPF^W9$[ZE6JDVTGX)TW\#8$X^@3]/YP6% M3.Y[5N4JS8HFW0#9;M_OU\W@;5!.C/82RQ+>0N;I*/FXEZ`J-W20%62.(^)@ M\C`/9M=IPI2]V4&I^+9=M?\`'>T7WTPG<4H<:_K1_H;J8MH,7%,H\J[UX$>R M09$=R+A1[(.BM$"H%2B@B80Y'.C&-)-?RH[]J$8+VXU MZ(JB;W=#`9EW/C=<;^[+4;M?:-?]>Z30&]2L>A92\SK*N0^U-5_M1*3N>QV5 MQGEF$=*SL1<%'D2_@FO+F)29(*J%4!Z10>1#.=C+NQS7[=I)=#EHI;UH^+6F MFZJ5)I)Z9V%V(O.R=7S4]#RY2%3CYFM2#6321=%\?EE4Q4#@1S3 MLEF+[8IWUTQ]R4M=-*MU?AQ*78__`.![F1%QC[C?JTTZFZU=-.-=O@3(G]5# MH0K;YVCUW?\`#7%W3GQXBV2VN*=L'85"I[YJ84'+&Q;#HU2G:'"G8F)PJ"L@ M4KNFRXG0_SF+&2C"DK+2?6M8KS:T1GS5[36KG! MQ-GJ$_#6BM3S!&3A)Z`DFDM$2T>N4#(O(Z18JKM7C90!]#D,(?9\Q6`D(R6=E@:E$+S]FF%D^"MXR"AV_!W\F^7,5-(@F(GY&Y.^374(BH)FXO=K$L>[!1?5K%I?/Q3_)Z.AKOMU6V1]$*Z3NV-0P=GV=])BYS[ MF>W)I&$1>V*Z=#K#//Q5E]JZ7C">_(377MV\3?XW^#UHSEW7F=DO=-N+EVUJE%_*V]'\MGM6BDZT9LJVG1>K7 MU0NM1ZY#7FO[+UA8I"HVNI;4UC,INI>H6&*=1MBA+?K2[1:A'M2OD8S4\$7[ M-9-['&6.FH4!`Z8W;ZM]TMJ*^E23KQT:>A8R[4.]=O6+8N)34XMSY4:;7#5K M34S(I-+@=?5B%I]91<-X&OQR,9&(O'S^6?\`LI")E'$A,2SI[*2L@[4'W%W# MA51994QCG,83HU2YLF;PD@S9VRN0]A9,WZ8![;QHTEV;Q%N[(8.05(`*!]^17(*= M*QC*G-;>1%JO377%IEM:07>/MG0>N6U[ MW6G!XN8@=,EK]ENU[@(!ZW$@QLA<82I#&I&()>45#I@'!A#./WR[=5BS9QTJ M7;L8/EJZ?)/AX'GN^ROQL8^'92Z;][I?*G51>%%R\#:-HG0VI>MFJ:AI/1M% M@M>:RHT8A#5^KU]BDS:I-FZ8)*/'QBD]^2EGYP%5TZ7,==RL8QSF$1SKV\+& MLV?MTM*5?-OQYG>LX>'CP>-#Z5'7Q;WKS;\37OU@V-`4CZG_`'/Z>:R%`-8P MVD-*=E)JL1@%+7]5;FV1/VJO7*!AVR(@VA$]C0,5%V%=@D0B97PN7(%*+D_/ M.QKBM]PEAPT@H=5/'TI_MU\3C=MN1M]RNX>/18JAU46REZ:^6[T-NN=8]`,` M8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@ M#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`, M`8`P!@#`&`,`8`P!@'6J82IF,'J(!Z>O'VA]N:7).$'**JT:SDX0)W&]*7=];Z6U]5-5ZLIT!0]?4>( M;0%4J=;CFL9#P\2S)X(HMFC5--,%%1Y464$!466,8YQ,8PB-VW;MV5TVHJ,5 MRT.C9QL?'M^S8A&%KDE1$@\!]P?TS>K+%65P8*"`#\0`?XXJUL8<8R^I5,=N MRO7:J=D]P2]@MGUCM&D2:;:45IT2JJ?U5K5>-=2MGXD.X8ZQ?IN1HXR6\6M MFO$U/N>V_P!5/8NQ.PG3G2>F>I[#L!U^=T:*MG8/86SK='T9U4=I5L\[1MR5 MG2K*IR-@E5'K9J\37BSRPLVLJS40%91(`YY?W?EBV[<97$OK;V3VHG^GR M/,SS.\2R9=NQ[4978)*5RM&WSU\*>"Y&3O3#IOK#Z:&H]T[>W!NI;8.W=H2K M_=7<+MIM=^R@UK7.1K)0QSG%4X1]4UW3&!U&\5'$/XHI&Y]3G`"]&U9L8<'D M95%D=.LN/BJ[[_-GQVNQ/(RJ1NN.K\?/=Z_-\.!$/1'M3W'[I=C=H=D* MG2XNJ?3$GX>(I6BEMDC.P6W-JS%7-*?J^_Z'6UF@_H6NK0\<)LD&S\$`D&K8 MCQ#\PJ">IAY63DW)95M5QGHD_E5+GS.3V^]W._E2SXN4L*3HHMZ);52Y\7P^ M.INB]TO'`*<^@?`1`_`CQY<#^.=>5N4HJ$9-27'F>IMN,ZVDZW%N=Y?[0Y$1 M_$?C\(\SYUSG!%0 MQ2>9BD$2D+_<8P>H%#D2AR(_>(`.:9-RY9AUVX]1K.<5!RAK)+8T\]1.UU!V M>WD^V>WN]%3JA;.]M]/G.K%FO6JZ90-"C4+3+0;.JRT/8!CM@,=NPJ\<89R2 M?/`(^.L*:#5-J1$QN9CW(NXLF_E1C%__`&VTDO#5_F>?[?E^_P!69E9,;:3? M]MM**2VWU\:\?$D[M]U&ZW?4\U-5K/1]I5Q#:FJ)\ESZT]K]-359N%CTUL^& M73DHV3BIJ(.J+&7B8'=K:O3Z9W8JL:/3FMM6JJJ^:0^GEV6[;[:9;%U#V]Z\N*)MWKM:5 M]9[`WE6G<O6IV\E:PN./FDDZ^>O#3COHHNWYV;>B[.3!4A-QWX+]:UU3::H]-C9+!U^ M%K;88^!BHZ'8"X>O19QC)NQ;B\DWBLA).Q2;D(0SJ0?N#KKJ#R=54YCF$1'G M+<;5JVJVTD=Z%JS;A_;BHOP/1@Y'GD..>.>>/4!#,-- MM-.AB2K1K1HT_P#<5%SU&[L:,^H.5JX_PAS_N?1&\ MY]%#R$E4R)(^M]^MCTA(ZGZIU-2(LJ2\_99=4B;5DQ: M)@FBF'FI[:*9SATKV5B=OL^Y5*#5%%;5X<-/V+Y'8RLNUVZRIT2M)445]3?) M+;EY(@[H]3.X3B0V;OSM19VE.4WY,L[16.HT:W:ST9UR@6<:RC(*,<;#%4'T MY?YV.:$"\JZU\/GKHN=VG#SHW MY=PO2Z?.0'CG[>1'XC]GXYU+4%;MJVI.4E77XU. MWU)\^KD=G/\`7-T^'$%==*C%6>[R"JTG: M+'%T76]%AU61[KM79%D5(VJVO*'%/G;%.6LDZZ,`%`RJ2#=$IW#A1-!-0X4L M[.A@VUU[R=%I77E_'9%?*SK.#9J M-E4D%U!*!S0QR[D)6[.?%1=Z73&FM72NM-M%OL<6WW'*M7X8_/F$0V!U:I4C=$?4Z#ATN!?'\P\%S?+[7@3BYW[X%YV]]-^I(4+JI-Z6?U'=IJ'`6" MF:%V+OEK=(5U1'NO*K-L(N.`]1,/Q'[/-PT=8(^0A9F,CIF$F(]W%3$5*M&\A'2<<]2.W=Q\A'NT MU6CY@[;*G3625*8AR&$!`0$0S2];C?LNS)Z,TN^NT[3BIP?!F(,IT4T]*51I M1#OK\PJ-7EVEDU$RA;B_B+#U_LK,KE`DEI"^,_&[TA@HR=&;#%@_<1968BV* M@5L(HY46'"Y#V;J:M+;75/P>_P".)S?\3CNW[4G*O56,JZP?_2]Z>&JYD9US MJ1UHT'M.-[$;TVU<=M;B@8B7:4#9_;3;,/._XPKZ;0J]C+JV'>-JM0:2LLS* M!Y.081Y)-5$/]YP*8B`T%C8?;KCGE3E=KMU:T\OQ4CQ^WXO;Y_<9^0[N51TG M-[4X):+RTK4C:R?5,HE\O-:U-T[J+KL#;;N2SA7=MVF1:JJIQC\VDBK=_ MY!&JQL:+N93BVI.L(:*M:NFRX?(\CZ3.^^TW;2I;R[,[SO50G]1V[;=DHW5J M"UY2%:;3GFL=7RL_>#YQS!)4J*8JB`5>RW9FNL77;_I='1?!+QU9MW3`$1Y$0 M```IA$1'X1]/0!`DDVO);B4HQBYOZ4F_@CG[ MR8<"(B`&'@!$H\`(\\<^GY>>/3G,.<4Y)_R[_CB;M4572AQ%RD`\?GY^[VS^ M@<\`(^GH`C\/OS>2Z8]3ITF%TO7JC\T>.3?#GD"'$H>H!^80#@H\C]O MPPHMTIQ_=4U4XRCU1:E%2IIKK\.'CL<@O]O_4/ MOS&TG'BD;-Q3Z>J-:5W7$%<)&^`F]!`/4AP^(\!\0^W#HFXNE49=%)QK'J7B MN)V"G'B`F$>>..`#D1YYS5R455[5%&=8.$Q^'GP(^//@;CR`?$2_ M#X@(?],RVHR4']3-G;DMZ5I7?6FYS]TGIZCZAR`<#R(>GV!Z_```.1X$H@/'KD=V<;,.NYI$R](J3V;*BNF`<\CZ?9XF\ MN>`-QX\<\^(\\9O'U-)<57X&)OHBY.K2Y*OY("NF42@81#S#DO)3``_P'CX_ MA\/(K[Q/\`\N?_`(^!O(/M]0XY#TS7JBX]5?2E7X$O2^KITKYG;F34 M@W?N^Z9UZHZURN`2DBY>OFM>I-+K#!:;O>R[Q*D6+`T*@UMJ47D]9IEPD($( M3A)NB51PX.DW255+6S+WV]GW/]?@5LN]]O:]S_5^",?-M];=0?46ZUPE=[1Z M&L%(E)V%"09P=D=0S?M8B!AKMVHO=->.QI%,O-LM\58-?ZPWA1(%R))*.%F9: MZ&$%FRJ8"H1QR\B/D24)0E6,J5UI15JULFU\D^9Y_)A>R,JQB=QE[2M M3ZK,DJUDDTJM\*-\M6D^#-D.M>D'<9A981Y;?JX[\W!IA)8BLK2@U%U_K]KM M35HX4(,6;<5,K3::BV#D4A1>*QZ"#XX`8$UT3\&+-:[;W&Y>]YY;=A\$J:?- M[EJWVGN.1?K/-E+%Y46WG5_/\C;%',FD>U;-&B2:#=LD5)%(@<`0H!]X^1C' M,;DQC"(F,8PB(B(\YV865;2IJZ?`[\(V;:5N-*Q5/D>@``#C[3`&:3=$GXFLFTE3F0=OKKMI3LW1W&MM]:XK.RZ2I+0T\6 M$L\>A(-6\W79!"4AI5G[Q#':O6+QN`@8@@"A!,F<#)G.4VF5C0OVDI:TU^6I M5S<#"R8)Y+>Z?Q7XH:I?K;O6D]UGTYTAUW4XY3:_=C>-`Z]Z:DTJ\=&(TVP* MH:7O>U8B79(-F%0FJ)KJ-?EC`17;.55%A31*=(%2YR.]3MW+-O"QE2_#'/Z]:/M MXEF-:=%M*O#X_BIV<>-C!QXQ5%;M12?"O%_-Z\=:FG*E?4)[27Z5W%]1FO:[ M;UGZ5NMJ8WBXRN[#2EX7=N]J;6IIR[NW;G5\$_\`EFE,I]>AU%1C(>1*"]MB MD#*D%!<$//DO,OJ_++3_`.SFDHI\XO5KYK\5/.VLJ_#.O=WJ_P#'1C%=/Q:; M7C6FW#35U9OUKDY$6>"@[)`R",K"6&&C)R%DVP\MY*(EF:+^-D$#"`"*+QDX M(H7T#\I@SMVY2E;4F>HA*-U+)M_[=Q)KXZH]S-C<8`P!@#`&`,`8`P!@#`&` M,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P M!@#`&`:GKTOV62[J["G(.-VQ):R84:W1$#5H,T_&'.X;Z*_5(>V5JQ.S.=2R M-7G+_P`Q;6*3O+N#[[O\`;JI5UMTZ M]$J=?7K6FAX2^N[?_P"HNWH*]]JK,HQBO-:BW.L,FKD^M*47;5:*;M_C\,];W7WY8\.E.72TVE_-S7/R9$K/7-\V)V%[ M@52P2&TZ;6K]2JS6M:V!)]ME@2I*RVFJRE-3=&L#*42ULU6@+B4QCG23!^,B MF;P4,0ZA/+Y:/\`@0SQLB_G/HM2C%VZ+5\5\M'OQY$*6V'[ M36CK:TV#=879M5VS,[:ZV:UGJ7#/KT_&-H&IM@,J[L^]KPFOI1M/_MK:"@R\ MP\59J)O5Z\LU*8P&+XASYV\YX,;U6IN^HTUITJJ;^+U9Q>X8V>^VSE*S+[BY M*U:BO5IT:3EIPE0N[)6D)H\6VD4P8*HE3=I'<"H0XB(C=M8EQYUF=V< MNM8ZJM=S6.!:CW*Q*[9G"VTY&12O^2`U^;:LK*3;YG(0QQ^0_23N&R:(F,W%(2@4`SD]KQ^YJ_B M.])N'3?TH]-52K?YCKPT)O[3VKL&PVW MK.;U/7K=*ZZT@Z@+CN:OPS67]W;-5G?>8<+#?L6O]Q;=2=%3\>9" M\'K_`+$Q='['4VU#MI[&=>=<=@ZOH&WM[!8GUGWF?;<>]NNNK&W5BY$)Z?LF MKZ\X:UI(5R@Y3ER+*)<&X-D=NUER;L2DW%:Q\5+5?):%?$P,Y7K]G,BY8MJW M=Z)*J#-LK*R=0WO`&VGT/5IE6JQ MC6:?F*KV(5N-J?\`Z!85H!]+L:U=6\78V)$Y=58C=5LR.)7/@AQD5F>7**G> MJKLL>-5REU:U^!%@XW<(XL/NK$ON'B1KJW2?7JGR="4*:6\43M5M"R7]#9#F MC5C26HU(0"1^V++$.I>)H5E'8QJJI&2*]"DY07K%JF\(NU7DEW:B/L'\S'R> MJM]UE>OR=%&*6_\`3\MR\L>Y:[N[]U2A!1AIKZO0J^&CT_82IWKE>Q)NN=O- MUNA9!_9)"KSSIZ]A)E6O;#BVR,`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`R7^7H^S!,?-KU\_RIFADP.80% MKF,K&SWBOH;4>GXM_OKRX'/S'EW.U2L]L62[TL.7N5K52J_#ZJUVX:E]T>'W MZZZO[GU?)0NQD]L0]_KEL@6MANNPVU?149G8V)85RY MK[0K=\L,(*D4I'G;(51L@#-?W57BRAX M\&XKF9*[D^F]"-%'9>+_`&R,S-N7LU^W>LQ47'92K77STWVVIHT9 M=SU2ZQ_59ZT2-9V11S7733O;$BP%C+M_::3RIID/)52POH`3 M,YF,4(5]&.%")J^!SCDT)R[MB1G-4BKGSI^A*:HLHZ,CF2)6[1BR:H$31;MFZ!"E(0H``` M&=2S:]J-'3]QT[=BUC8RL6MHJG[CW@^`?P#)'N21^E>17!D8`P!@#`&`,`8` MP!@%K6BG5FXMHMK98.+G$H6>B[/#_J+9-92(L,(J9Q$SD4L)1582[!4P^TND M8ARE.8.?$QBCGX$?M5T-->_^E'8/OIVVF-7=U9.O(_3CU7%0%UUUIC4[FS1; M3M+=95U(-Q'L9/K.D'S6/U6J@B=&N,EBM9%=9%YYF*0Q"<.[8O9G7/FG7]-V<6[@YF=W!VLM_P#ZVU&L*:-NFM7P=:^2VW;,UV\SN&'.UDS M_P"RMW.FVN.F^NFFR7EX(W'=H^S&E>A/6R?V_L=PPK.N=7Q-?K\)76RZ362G ME2F90E?HM`CE/<7GK7(-0!"+CD"G5WEYEK!L.YNXK2/%\D=_- MS+/9L&,Y+J<4J1XNE%1>2U?@FVR9]0;>U[O'7M:VEK"QMK-3+4R*ZC9%NFJW M<-UB"8CZ(FHQT5&1@[!#.RG;OH]TDD[9.DSI+$(Y9D^DL/9.RZ-J.D6;9&RK"P MJ%#I40[L%LM4N91.(K\&P(95]+2BR*:QV[!FB0QU5?$2ID*)C"`>N:7[T,:' MN772+XD.3DV\&W[EUTAQ?)WJ,IKNQ;73WO23Z^J%K@J-;+`563$*S M;K2:,+6*_/1?Z;^M1,C91FF?Z>1=L3YT'20HB<%"B,7WN+2O7IS*4.]=IN67 MD0OIVEQU_=_J>G:NY_6.D5.F7BV;7B*_6=BS4_6Z3(R<59VRECGZLG*+V.%8 MQ@P8RP2D,V@WBJZ"B!%"HME%.!(03!FYF6+=M7)270]GJ;ON>!#%CG1N1=BY M6DG76CH^%=TSV[#VNZ[5FDT+8\GM>L+4O:44O.ZZG8([VU(W6!9Q1)R0G:XT MK+26D).%BH=0KEX[31,@T1,!EC$Y#G#R\?ICU-=,VTO@22S<*W&%VPI34[2\1:^R(/7[+:TK3T4))689ZXDEE&T?<1239&35AGSI$Z M*1TS&,HL0Q"E$Y1`'N6+,U;KZI_L+$LB$))=2H]?@6$9WKJ5J:JE1ZZM5VK33D7WJS;^N-U5;]ZZOM#2WUDLK,P*L@Q;2#0[ M:M75U6]?$LXV5C9$?=Q M9]5K737]>1;,-V1T98)*^1D1LFO+JZR8RV9^W: MUQ=G7Y:'=-7ZB#I8K%RV527$AR&*$"[A8UBVW);^"(WW#&ZG=E=I""U7+\5/ M"H';CKEL^VMJ%1MJ0,S<9&L+W:$K*S::A9>T4]J9+69C7Y^U"7K?/2J^)IC=R[=?O?:V)J5V5737;FJHK$]N M.N$Y18'9L-M6`DJ#:-BEU)7[0T;32L9+[+-8W-/+3&9@BP54F_W4R6CA3\0` M'B9DA$#%$`6YV'!)25)3Z5XOD67D8]N,9N22G/H3\>1*3?9U$=["D=3MK1#K M[+AZC$WV6I*;U`UACJ9.RLC!Q%D=QOG[Z,5(2\2Z;I*"'!E4#!]W.5K>5?3KHUOPH>M0>U?7_9U\L.L*%LB*L]^J6V[*:)=:M8[J#9M:9ZJD)UM6&UVF%W$%&$LCVWIT%M`NTYM MM'OF$NK=5"QGRZR2:H.S>`E`'[ZO4MMTKK\N9\. M[.U'7KKFYKK'>&T*_K=U;FM@?UQ*?3D^9=E46)92TO6AF,>\(+2NQ9P=/5#" M4C5M_NJ"5,!-D-S+Q<*:MSDHM\Z_HF3Y&=B8-S^_-1W.\D^ASZ?\`IWJ>7J[N/UIW997M-U;M M2&N5FBWMCC)2*81EC:J1LM4`8C:8>07E(9BR934`620,Z9*JD=)%5*(I^N0V M>Y85[K=MUZ-Z)_JD1X_>>VY?5]K>4G'?1Z4YU2+@D.SW7^*T@IV3?;4J26A4 M(X\LMMA%^+RG)19)<\"J_-(LDW(%9HS29FQU!+XD5*(&XXYRU;O8]S'68FO: M:J6H96-/'^_ZT[26_P"5?F35'R#*49LI)B<7#-^@@Z:.!(JC[S9PF55%7VEB M)JD`Z9P$`,4!X^S)8V[=R*O+9JI-"%N]%9$7Z6JHC-QOS3;6E7G9#G8U31H> ML9FT5[8-L4EVI(6G3=+D!BK5$SSPQP)'R$%)E]APD?@Y5!*'`^1>:L,W&N6I MWDUT0ETM^+T_4IK.Q?8GD]2]NW+I;Y/8]^S[0H%)>4=A;K9!5M[LVTM:3KYM M+R"#->WVY]$RS=LVY25;WT^+T.PNS:$:_K:H+;8+_`"8WIS?82M%^?0"SEH[J6=0*%I)# MB<'B\*:99J-173*8A%R@0W`F+S-UVHW)6JKKBJM&[R+$*KT._K5D5J,^V?.I-NT,BI%V=$S)7DO` M.2B0!$A"NXXDL2>=&:=F,W%MYLS=>K- M.Q<),;,N,34VMDEDX*KHNS.'LM:)M9LH\)$5>!B$)"=LQ,>TNNYTQNNJ\7OH27<[%QW;5V:3O+T^-%7]A%[KNGU>8ZTM> MXI/;L)$ZVH5K;4>[V>:C;'#)T^XO%8E!C7K)%2<,TG(:2>K3S(B)%VQ`5.[2 M*01%0O,$>Z]O;]Z-WT_3QI7QTW^!3AWKML+'O2O+VW/HK1Z-K9Z?P+_@>PNF MK(2AJ1%]AC?Y2G[%5=>-W_S<'(6VRU)C)R=E@XF*G&L=)JR<+'0KM=9$R)3@ MDW.8`$`RZK^.HQDI+URHO%DT<['2C+J3C(-$FCV M+>3V\!7)W2FOF#NO?NQLZL;=HFNX9$5K/_O``E$P-?\`<$`+ZYM*[8;G!R5; M=*^'%&\\W'3N1ZE_;:ZO"O\``CRN]P^LEIUX\VS#[AJAM8Q\A3(MY>I0\C7Z MTB[V(M$(48WZG8&$6W48VE:>9%9NB"9JL+DG"GKZ5XY.-.P\E33BN.O[B".? MAN'5"2>-QEP3?,O"[]@=.ZWL#^K76ZLX2QQE!D]IOH95A+O'J6OH>390LI:$ M4XZ.=@\CV4M)-VYBH"HM[RZ90((G#-[EVQCQ]J\N99 M&L>X_6G.GJRS:25A@)%>2A631A/0S!^@ MLX9+*$=)IJE,*?`AF+?<+%WTVVG\U^U%>/=>VWKGMP=;RTV>ZX:I(E';>Y=8 M:)J9+WMNWQE&J)YR`K99^8*[&/">M$HWA*[%G.S;.CD=3B=9@]*F9J[(0PI*&\3<8M9-F_P#[;J06\ZW?7]N2EY?QH9`!\`_ADI<6 MR*X,C`&`,`8`P!@#`&`,`8`P!@#`&`,`8!\BRJ:!!64.5,H"0HG.8I"@)S`4 MH")Q*7\QA`/CZCFWI@M:*)I+V[NND?$\AY8(&.^<%],Q;$8]-NL]!U)LV MOR2;PQB-E77OK)_*IN3E$$S'X*H("!1$I,K]N4ETRM_3U:.NCT^6IW'FXE%!=TK)L$6C5<6;MTJ]:IH-7@+%;B MS<+BM[2+HJYRD]LP@<#F`O'(\9GW;*TJDS?W+2A*;DO2Z/5'0[LD&Q!2-/N,;H4I2 M235==#FI/PR+EDS5E8M-Y)%]R.:*/V:3F0)Z"!F*"BY5'93@(<"F!@'G,.=F M6C?B9C>QI2I&2ZOQL<1GX7WS-OU:/!=J+YK[Y7ZJ1ETF0H^][I7JJ!1 M.5+Q]PQ`Y`./7,*[8FNGJB_B:V[]B1N.?$OJ/IF)6[5JLFZ>Y^-#?WH+VU.B]RM/@?"G8(150[=.5 MC3N$2NCJI)OF9E4R,%`0?'.F5<3D(R7.!%A$`!,X@!N!$,Q;G9FNJ+5%I\B' M[O%C-I2C1.FZW/J))1YT6S@KML=N]\`9N".4#-W@J!Y(E;+>Y[+@RQ`Y(!#& M$Q0$0^`YM[EF&TE0FG&W)>ZI))_F=/ZY#"+\H2K`31/I*`#QJ(Q8^V94?U$` M6$S'Q1*)Q]T"?D]?@`YGW[7-$;27\ZJCL0EH]TFU6;OV:Z;T@JL#HN6RQ7R9 M2`H91D=)4Y'1"D$!$4Q,`!CWK']2->J?]43YR6.`59JR".3``ZJ[9E6?4J1=-UQ=#92A*#:E& ML?%4JW3\<31[W%U]W#Z@=CU/J6Z<>6?N%K=A3OV'V.ZJR,+`C=Z)IIM++S![ MUU"5CX]JY8V2KD4,YGH1959>T(H^X=0RJ:)4>+D6,[$R?N[;C^GZ716V;+V$[O=:Y.JKZ>[ M=O\`5;Z(;5`&31.7LVLJQ*P-LN]PKS/V3578TP^FDXJ58.TD9)/]"2.Y+YG# M)^U>U>R+F=C24+4Z+H=-XUJZ)Z5).R6XYE^]W7#E[>/.D8P:2]4*J3:3_F>J M7QXJL@]O?IV:([F[`Z_;!VFE:6DIHJ=LSLZM)L4O4)+8=(M,*9C.ZAO$[`R4 M7*26K[!)H-7R(WE%UJZZTT=/W?MYEW+[99R\ MFW>NU5R"?5TNB=:.C_\`;YZM;-F<<%786LQ$/7Z[#QT#`04>TBH:$AFC>,B( M:+8-TVK"-C(UF1%FQ8,6R14T44B%33(4`*`!E^U;C8MJU:5+:X%^-N-J"L6H MI65RTH>X!0#[_P"HY)5DB@HNJK4Y9@V&`,`8`P!@#`&`,`8`P"GB'W9FK,U9 MTG2`P\B`FX$I@#RX]2CSZ>OQS*=-5O0UJU7DXO\`'@:?*99]+_13Z?72+W_> MS-=55S;VW;7J>5:1S^8N>Q`VU>);8L1KM*(CFKA%;8Q+!:EHAJ3W")R94B.` M%/\`W@3X-O)M]HL].6^F4YS<51NNB;JXITINZT5->!YJQ_>C%[M0D;[%5GK7]/VN.%9NQ]3& M&Q'[%A0>Q-K@%%$:OM+=ARF,M8F[WYZR.@$2LY%Z]#.O14X-^F M-:4JJI[T:\'KQ?"E2[#.R[^/G9=E7,6N6HTXEVCDEU+E4PY^H)J^\[GZ1]J]2:TKQ[3L#9FAMET2F0!)&-B MOU.RVJLOH>*;*R4NZ91K%N9T[`5%5E"D(0!'\,YO=K%W*P+MJVNJ\_I5:<5Y M/9;H1=G_0JU573^O+G9.R.Y[ST]V! MMQ%[>24?3HIM2:/KY1I"D044!18"&4.J90Y\Y61VJ M2[=%V+QYV]VJ]C_\?ACX>/8U;V3V#<;5L2^V+45UVEK:I36L-K4B#NDXV6D5 MZK:7!9FZ-?".:%>.4XLG!S`L439MGX6;?Q;%G&ZXR4FY-M2EJ^+;U?.A6[MV MSN>9VS&Q,2S<@XW6Y=4X.:BY5;;ZJ-NKK1[:K4@RX=5>T$CU0ZW:HJ'7:WZ- M[4].8VT1O7S=FC-JT!WKEA>HLD7!-GD]&VZR)2,_H#L37U%7%HAI1BN^CC)' M;^T94C=E7J^*WUK7;30RLG^K^Z+EW^L&Y[0UV)5Z*KT6H>JU+OIW8L;4&E@W#!;`M M-PL%=)%FD#V3]"3:2Y`CUW#NY_N7%+V8V51J5%U\FDT MVO!Z%R[V_(O=P=V["Y[$;&G3/I3G3Z6E)-JO/2IC?K/J)V9J_1_Z7FG974LK M_D+K-V]U_LK<$.-JI#E2#HE3L6TI-_8FLN2Q!&6!PLTN#$Q46RAG*B@K?D`2 M\&YR[9E?XZQ9Z)>["_U-=2T57K6M"A=[?GR[9AVUCS^XM9%91ZUI&KUKU4>_ M\"\]O=&NQ%PWKV\[4:&0:Z9[-#98R(U-/VB38/\`5?:S1J>F:959G2N\*_#2 M[Q\RKW[NA7RL)+*I(2D`]5*[;@9!19`]FY@YMV]EW8*4+DXJ,-4U*-*/?9_( MM2P.XW\K.NJ#M.?IMNL6IQI1Z-^EOX%W5[KAV0T9O3IAV)B=5H;6KU(Z)P?4 M7=&L:_:JNUONJ+*C+5JX'V'KA:S24/5+='.)2.4B)ANB]9NUFK9LNC[Y2&2# M,<&_96/*%MRZ+?1)=2JMW6K==WLOXDT.VW\6_C3MVOKK5OF]E MH9J]+8OLFVUA;7W9UJ5C>I_=VX9NL1RJ=)0DHO3SF[R`:B;V(M`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`027$ZPCSP&^%9R;6?;W>2LY%B] M8LQ?4FI6W5\$_7^E#F=QQ,_OCM8T\:6+AJLI/^VWU+Z5Z9.E7O3@R+I_KIVX M[(//IGONP>L;)5;!J>G=D-;=M[!5+SK]5VU4O^G$=1(7&J/PF))23C]E':J/ M3"U0,^CD'I@43353`0BO8&;W"_CW-"#.[?W3N3P_N; M,XN/^ZXSBJ55'3U<5O0R=J76*RZS^H'IZVT#69H7K/JSH(\ZTU^;;34,JS@9 MV/V=7+%6JN6&=S![,Y8-*C``G\Z+=0GS/!1-R(FRY#MURSWBW=M*7VENRXIM MK1NKV;J]7R.K'MLK7?[5ZW:;[?;Q7#J;3]3;=*-U_0@_7^C>UU#TEW\HUYK-KNSDG:0_2J^FM[R-7@9#<0)EM!!"6IM2:R+TD091-XJ]*@F4 MGBN7?1*L76+>K:K3;GJ7#$QT\J[D>B7]M? MVY/U2I6C=.>NICM8NBW:K6?1KZC/T]M?:]#8NN;@0;+TQM$5(T2F0JS#:3BO MSFP=2O8"0M)OV2SH-\:R+MF=8GRCI@^$2*>X'MAB>)GV,*[V^S;=RTZ=,JQ7 M%5TJMM3%W"[CC]NRNTV+-ZY9E3VY+VUJVG+1S3YTKR\3>;J"VWBS4Q5[;]2V MG5SV&4)%Q];M,M3I6?F&T=&,_=DTQJ-BGX9J@]?>ZBV(J\!4Q2`H<$RF`,Z_ M;YY7L2MW[3M*$5&"ZE)R]*UW=-=*>!Z#LUS,6`K658G9G;@HI2E%N5([^F32 MUTI4_.M-?2O[BWC47:#6CM9.!U1VZU_M+LCM36,A=VI[DV[YL)^XK:_K\)+L M)1U`H:QOYW5:FIA7Y@$2/ZRDF(%(Y5*'G MV8V39.'W'-MN,KI/JFFJZUTI33F6\K`[OG7+>1*U*U/%M+VDI1? M5.JZJ^KDM*_J2/MGI[NCM=V$B^QAJ_;NJ.]Z/U?U"OHK=#66J4^XU=O6.N%_ MG=FZFM<)!V242O\`J2TQTZRCYY@X3482K(ONMU$W2*2A;D<;,R,OWYPE9F[' MU*2=+FFE*[;T_,MK$S\[N:RYV;F.X8](2.BJN!SK'8.ZV^ MVV.S7)?VKF1>N7[BZ:I.4YP25>+Z4Z;'G:]T-WOK4Q]/??VR-8*;0V+TPIV\ M>L6X=?&O%*;S&RZ-;DJU6*AVAU+)OIDU:7N;ZO49BM)1MRG*.GT]D]$]Z>Q?3#O%0[%0Y64M.S>TFN9?K51G$IJ.L7&/Z_TN[: M:L_S5JGH212@T+(U5K=^L5Z%)V_ M.M*^+=4\979;]KVNJ]/(K&VO;4NCGUU2;\W7D=O:CJ;V@[%Q'7N1UK M7]J4^_\`5QKN;?.C[GO#8M%E[$;LC$6NG+:EK6QWE1FW:+NEWRE)V2!>>V1< M&4/(D]X_O&],W,;N5]6(V[-V"AZVYS@Y*=52M):JGYF9=O[MD2Q[4;-ZWCVO M\*M2]5:+X[E=7]..T>L93ZD2<_5E;J_[N]7:O;7]HC+77C14AVY MD]=[)I6Q:M^I MU2K*FB2KINU5?J2V>V]TL+*E>A.].B1[W6 M:H;NZXM>\EKLNC[%/O\`;'U`+-M76%?BI^IJO++K3:9-1T!O:DUFLM(HPZE= M1B'\B^:/"(+@R;?_`#/R%V&/**N9%^#C==STI.N[HG15YU==N)8LQS,;[BY> ML)UR?[=*-N,Y;T5=JZUV6KT521?J>:BVQN[JJ[HVFZ.IL.\I;FZ[W1M6$9JO M5X7D)K7==&V#95/U6SR$9$MUDX.M./8`ZO)W`IEXX$1"?NUN_/$2Q8.Y?BTT MJI:ZUW:6W,L=^MY=_MLK>-:ERLK&ONYBW+>0[+C!.4'6JV;4]->) MCET%ZRV3K9K7KU(6O4=B7WG;^OFG-)[_`+9(76G/&FJ(CK[K]ZRI]3B6$<]! MM-U9U:)%^5J:,^:<'7?"X=*>V!0(P,18]GU)J[36KK\O`T[=@2Q+,>N+E=DM M:OZ:<%3N=%;:[G:2HJ;T*X,C`&`,`8`P!@#`&`,`8`P! M@%/(/]`.9HS5SBM&.0_T`YAZ;F4U+8IY%^'/_0?^_&8;256]#:C6I7D/OS7W M((7\KMD[=BKN-1I336NI@ M+?NI'9B1U_V4IM72JVY'"O=FS)6,JV MK?7&YT=#;BVU'G5Z-+37?R+PW/TWV5M":I:](YUM7[WH1]JK=[IN[@ZK<85Q MKB?3V3H5U#-*&HC`?.-[ZNY;R*3!5-FG&N#IE\B#XAC)P,R5RV\:3A#V&I?2 M_4E6*WI]5-M-.1/E]ES;TK4,2EF#QW"D`MO6;_& MF_:374[1M&LR4OO*N5I^#Z%4V5>%%YV\.X&7%-N&58.R@11`443D$H MIEXM6L"3Q4\A-Y3MZNM*S>[HG1:_`ZN'@37:7CYBKESBWQ=8DYFD.K"YVY8W=6:U3;AR2+EG3[<#6C50 MU<.@DLBK',WP*-TS`9R&4L;"RXRA=O1Q14M+JPU9J\RGK&D[;F4JQ,V5F;],"8[/ MT+=&N]#5>_'=A.U-]`4JO*1+&QMFZ[1H9N#<>&BO(07<+NDKMJ5I=%M*75&L M755;4:MU5><>9SI=G[[9S;%_&JK*@^N#<6EZV^A2;KK&FJVJ3=6=(=@ZCW+V MWV/?:JC;CJ_8MEJ#Z$H[^PU9K<=7RK/259K$GM6IBA(GAIB7=RT:Y@)9H[4* M^29@FZCG!DE'*"NN/+Z M*R2Z--TD_5KO5;;$^]E])7WL*3KDXAE[;JZ8J=IF]@N;979^*3LFI+T-LD+^_P!5V1JE`SG7 M[;EJ;1.[VS1Q.E9N$(/8U+:_J9HI0%)"-D01!%11=`%E*F/AY]O$I*-,EY$F MZ./T2>O&FW#=L MK6@4YF\9:G[!:YM:Z+5\QB&U1H-;B)Z,E7$>@Y<-R."-VCA!N1HB4RBA1X`. M`'.CDXLE*$\>+XXUR=NPL6+=JW?C*5'2D$J2W:KY:[& MOYGT\['HQCIXI6(PTY7X!E`[`:!:XQ!KVG.P[71NX5'CYVV?>3('VL&;YBG^ MLE0,#J948GX9D.<>7'![ETTE#50U]2]3]V3U=?Z.G_4\W;[9W/W$YPE[713Z MUZY>])ZZU_V^G?ES)GH_5.\Q\]I`96F.86M-+?W'?SK>'M4>C(ZAUQOU&;5I MM)AG;5\4WS,>K))B)8P%F\8L'BB84DR#E^UA3=VWU1<+?3/J]2>ZHEOPUVT. MIC]LRY7L?W82A;I=]SUIT4DE%?5PUV/5USTZMM,TMV$H;MQ).T]R3=%@8N*2 M)1OUR'H5-@*?KM6Y*(*,3T/_`"G+5Z'7F%ETVY/)ZBU,)Q>%%7*]GMV7#%O6 MY2?N3G&FD-E)5\*TK\?$BL=M[G;[5?L3G)YER<>G2%5",E7_`*:N-=7K77(#R/WB(@/]0`1^/^OLST$$K<>F.QZMQ49&K]\@HF28NV&L9%W%E7"Q/(@B+F6 M`$DP!/R64'F_XNW]Y]U!N$6MEM7]WX1Y_P#P]^'<[=W$N*WB159QJU7?1)*E M'IOMPHM#;$0WD)O00$..?AQZASZ"`CSQG3\MCT7IZGTNIV8,C`&`,`8`P!@# M`&`,`8`P!@#`&`19N?4&M]\ZYLNJ-M5:-N5#N#$T?,P4FEY$.)5$G#*18N2\ M.8N:B'R*;EB];G3V-\NM[(1SL(VB3DK28FJVF/J#$%4X="\S$8]=$N]W% MDH5)[+E18)NQ1!3Y4BJBICQ8N+>L?V[C;A#;R_?^A!CXV7C)1R+T964Z15%M M^_\`0R1*7Q$?41YX^/'IP''QXY$1_'+I>.6`,`8`P!@#`&`,`8`P!@%!`#`) M3`!BF`0$!`!`0$.!`0'T$!#`/@CXF*B4U$HJ,CXQ)50RJJ<>R;,DU53#R910 MC9-,IU##\1'D1S2%N$-(127@J&D+5NTJ6XQBGR27[#T,W-Q@#`&`,`8`P!@# M`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P#J.J0ATR M&.F4R@F`A#'*4Z@E#D03*(\G$`]1`/LP*,M"Y7RJZ_@W=EN4XQKL&S620<2, MB98J)%W"OM-T0*BFJNHJN;T*4A##_+-?>M1^I[%>659BW&6E'0M`^^-1E;,G M9-DTA9O)49?9S`R-A8K*/=ZJ4G/D/&1 M7+^'O;CT):+V=27<8[M\30F;PL^U32>7*P$;*P%::^^=([B7G4' MB*K-(@&^:15*HD)R"`X^^LWZ\74'*4\W!.>D6LS^W'#-CYF`/=)8O_0#S$@&>B#XJ1,3J"/]A`,(>1@#U],F:IKS+;3W+9NEWJ^OH%S9;E-,J_!M5FK= M:1D!5*B"[QM@Y?H MI?-%**8J*E(`^0\97>1@4_W%M4KONO;4J_<6]J[H]JL[-HUQJR]]K%HA9NFM M$Y8SRPLG@*L&1X)9PC-(.S_E4:.(A5FJ5TDJ0BJ!R"4Y0$.,WADXUZ'O<%Q- ML>]A7K#OQFFN=2T0[(Z)_:B=Z':E,)4EIA[7`FU9=--JE/1C87TE%.B'\'+- MW'QP?,KD53(*#;_>4\4_S9$LW"N+KE-)UH0V\[`5M3]Q=,I./R).8VFO/9A> MN-)F+=3B$4UGE8EJ\2JD,""@B!5O$1+R`#DT;^.Y M?V95E37RYEJ+L.?V]J594JUX/9EOS.UMT= MURE^ZY0_=$X@NY*I&09E6BI2NE0(D8R9@`>0')7I3] MZB[_`%U_4JK+-8*RS;5RLLW@Y=ZM&(M&$F@1(SYFX<#--#D`Z9?))RFJ`BF; MRR57[#M.?4O97$Q#N&+.$[BDO;@TJ^;H3+DY=.L0_,(^H#X\<_$/M]0#X<^N M9KITF$ZMQ\-S5'WL=]N>M=^K7=CK5'VG?.O*K6R5+M1U#3E%EG]KU3%O7DNV MVMUYC5@*U8;IH1Y)ZJ\8>0ELL8)$.`7;HB/)SHW\6<GQYZZ[5,XNMG8_37:_3U+WEH>YQUYUU# M.EV_-M9EA7L?^;ZJ\.-/Q\-"?LF+XP!@#`&`,`8`P!@#`&`,`8!$>X]Q4G25 M/=6ZYNWOBL\:P=>KT*T4EK;=[3*![4)3Z57T#`[G[+-./R(()\%*`&55,FBF MHH2*]>]J&FLOS*N1.%B+N)_W'PW\M"P-#5C2 M(^I>GZHTZM"J[>V)I*R/GOL5K6;NTS$J MU:2;V,G'DPX5JTA53QR[9N=/Y5O)U\WSG*J"AD#BF4PE.H4:F;8E??IJE3@> M.J=;6 M[Y^>YULC&OKMKQ,;IZZ43?+G7G3\]2`ZGUKVKKU[IF8I,!I=DZU%U;V/IUA" M2,S:7D8M=;-.TV9JR;V8-6AEI2G-#U+SDW!DT7;ARZ.HDV)_:%*W@Y,;UBY; MHX0LN+KS;W\3D6.T9<,NW?N=#4,25O55]3EU)Z[^)>^E>NUZJ&MI)G<9R)BM MHRDMM6RR3NH6">F*'8KIL\ZCV0N5RKTA&5II9G@3"PJ)LSM$FS1D0C8@G$#J MGFP,+*L>^[[3]SJ\=UO\2_@X>;9[>\>ZXNZ^O7?>M*\]_@8\:CZ,[3U9J]A2 MFLU2Y)9IO_K[MQ*.D[#8YUM$,-3%J`7)&&MUSQL>[">KE.M6ZT_UY<"AVCM>;V^QF4I3JJZTYZTX_D9 M$077.Z2F\-F;9NMA+6&%UI]5I(0>MKG:4UGZ=)N<[88&Q$DWK*,>4L'D/+?+ M241&G.SD'*JRZQSF\3#V[=E+*DWMT[?J6K.%FP[A/)E3HE&FCWU_"ISU/-F- M![D?;LN6YX>6I4%,-M*7C4U`9.I:PV2)FG\I8(NQT"WVF*DXDJ5.?5.29'4D MAASN%ILZA!6/_P"LW`*$,&7^2>2WZ/9E"GFTUIM70I8_9+W^2>=D25?:G"BK M35Z.FR?CSU(ONG1FUR3N'A*W9:Z-,G=0:>U?L-Y.C)#:8Z2U1N#_`"Z\OE-^ M6:K-GT[>I)^]!Z#I9J*3X4'0'/X&3&/_`!:N78UTA]OT?'KZJ^9#+_CTU.#L M.BZ+476K^B]&XVO.C7DZ$UZ/ZY6W7NUI'8EGEX%TC%ZR3TY5BPR\DYDIZK-= ME6C8+6S7%9^T;%1L)4YM%K\NB9PF50'*OO""Q2%LXF#/%G3^6*Z5Y5K5^/`Z MN%V^YBR]735)JJX^IRJ_'@2+N/3#_:&P=&60KN.0@]7V:T6:9;.A`[U\X?5= MS%024X M7;5USE%VD]G2M:;_`"_0?[U ME[/2[#5Q=2HUK]4EJDR&IC^H.S)HO5UUS*)-B<\!S'@9R44NA=*:_6IS7V/+ MQLVQEV5!^UB.VTUHY-MUIX5)$TCH6_:[UVHK87$,.U0E]GVYW&0-\M2VM[M= MMAO5YN0GK\1:`B3R2TG/+FY`D8)(MB8J#.A^[MK:M1@KS+:PB[_,[8V+M6[RM-MUYCB2=LNF MMRT>#L\=8TJQ'R+:*J)_%JI5SLC1^[#5ZCNN4G5>.W MRY'*RNP9F5C6X2<5NE$J;:[I>S?2[=S`]E<*259=7GKN>"'6_; MSR(=S"K=PTF@,$ MJR8IK(I)$%PKY5LKMV==5A1<:VZ5\=*:EF_V_+N9%B4>E0MPU\72FWXTV/8H M/7W9]0JF\G;Q2O2=LVON.K[CB*82_P!Q;5BM2\#^P3/(E78Y8$+I)5V3DZ<9 MT#`[(6B+%0(HI`9B;+]O&N0A<3IU2FGX:-/]-O@5\?MN1:M9$73W;MZ,UR5) MQE\M-MN!G7G0/1C`.I0H&$H"/']WPX_#[P'-9="UF:NCDHM5BS1IV,ZO;IZ* M;ENG??Z=U0S)$P#+;IT?'\%CJGV.@V`'5523*5K M9TDQ15+\R8#&\]>5BK^TG5QX->"Y:U\-UI5'GLW$RNUWON^WK_`+;> M<=ZKPY+7;=;K2J-H75OM-IKN-IBL[WT-<&MMHEG361_,W4CY^KV%APC/4NZU M]T)9*KW*LOP,W?Q[HA%D52_:0Q#F[N/?MY%N-ZVZPXKB=?!S;6;;]Z#]"W7' M\?MW1D:7GQ+R/(\!R/''(\>H\?9DU4]5L7*IZK8K@#`&`,`8`P!@#`&`,`AS M=.ZZEH^J(6*R?J$K*34HVK='I%<:A*7/8=RDB*!$4ZG0I5"*2OZ^)%6G]+VZ6N"/ M8;L0$;);G>L'#"F4J)>?J](Z]524(`NZK371B(H3ETET2E+8;/[1%Y`Y?EFH M(L$R)GCLV9)^]>UO/?DN5%Y;\V1X^(U/[G(;ED26J7TKETKAINZNKJS+0B14 M^?'GU^_U].1'++U=3H,[,&!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`& M`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`4$.? MO_D.%H:N*DFN9Q$@#QZF_D/Q_CB7J5'L8<*TJWIXE?$/X#^&:N-::M4Y&]72 M@\0^WD?P^S-N%#"5'6K`D`0XY$`_`>,RFUJ8G'W-V_@/$/QS6BZNKB9II2K` ME`0X]?ZX2IH8<4U1U*"0!X]3!P//H/X<>OX8E%2:;X&'!/B]SD``'WYM4DJ4 M$H"//(_US"T-'!-UU`D`P<#S\0'T'U]!YQQKQ#@FJ/@T_DZE`(`?`1_`.?A] MOIF&F^+,TK)R;=65\?Q$/X#QAJO%AJO%CQ#-JBCK6K*&3*;CGGT'D!`>!_A_ M`1_CSZ_U^_,F.GT]/"ARP;#`*"'/'H'I M\/PS5QC+ZC#7'B=*A!$A@Y`O/'YB\@("`@(L2BKJ'FX659GA[CKZY0YP:V M37VPJPY$LE4[K67P"B[9."%,`@"B8G2.10W3Q\B&59]ZU5OBN*?+\:'9[=F6 MNX6%>M536\72J?+31^#6CW1DV`\\^GP'C[/7T`>?01^_+!<*X`P!@#`&`,`8 M!01XP"%MV[QJND:VSDIEG+62S6612KFO-=5=!)_==D6]XF<[*LU6,,JF"RWM MD%9XZ5,FSC&1%'3I1)!,YPAO75:C6C;;HJ;U*>5FV\6*JI2O-T48_4V_QKR7 MP(NTIHNT%MBN_-^NHJP[YF(EQ'0D1$N%GE'T+3Y-1-9;7FL_?33^8D'94B?K M]C42(^G7!?$`19)HMRXMVGI._1W5RV7E7\V8L8TX3>3=Z99!]/3X^GVYLDN-'0P[B2Z))M>1I>[7=.]T:`W1 M8/J%?3AB&`[H?(MU^T_4U9W^AZV[K4R*Y]Y\R+P6,I_9&`8`?]$GRD`)$Q0: M/?<(IR/"OV+^%>>9AINTV^J//FTOSTWX-D6LF'N6M^*XIG1[?GV,ZVYVVOP+E)&KFK]5U@&RMQV-:S)F4+&Q"3I0C:.AHQ$/F966=B2/B6)#N'" M@%`I3PW[ZLI+>X]HK=^--Z+B]D4LW+CC048IRR).D8K67G3>BXNE%74L72>C MK%&6-UO3>\E'W+L'9(P8HRT8DNI2M/U)RJFN?6&IVKL@+H1!5BE&5F%")R%A M=I@NO[:!&[5OBU:Z?[EQUD_R\$OV\S7%Q9MK(RFGGTWX)0B'IS]@B(<^N3E\Y8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#` M&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8 M`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`=!R^13>)N.1X_H//\\S M./7'H9O+I:Z;FS-*WF*5HY,)3!Y\/*LW^WWEF8WJJJ2BN*Y^?/R3W MW\WW#`GVZ^NX]M5;E*2CJZJK;=%SX\Z56N^P/IYW#TSW:T]$[BTO,/%HY1P[ M@KC3;$U&%V#JN^Q!P:V?6VRJHY$)*L7*LR!#HN&ZQ?`X%!5(RB1R''J6+]K) M@KMEI*FJ\]CKXN=CYMM3M.DZ:QXK\<_]#*W)RT,`8`P`(\8!!N\=ZUK24'$N M'L=*6V[W"3"N:PU?6/EE[ELFVJ)F51A8)HNHFDV8M40%Q)2;DR4?%,2'<.5" M$*'E#>O1L1K1RN/116[_`!S*F5FPQ$DTYW):**W?\/'8L'0FC+#7[#8MW;L? MQ=I[!;`:E:23J.\WE8U)2BF07C-.ZO7>(HNT:Q&+)BO)/A(DXGY0QW3@I4RM MD$-+%AVW[E]]61*NO]*_I7A^TBQ,%V;CR;_JR9IZ_P!*T]*\/VF5Q"B4.!'G MU'CT$/01$0YY$>1^_+)T#E@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&` M,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P M!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P"GB7[@^//\\S5F)) M2^K4Z3HE,H4_P$``.?X"/P^X?7"I1U6K5#:+A%[>JF_@::>WW2_ MF.@;RSA3P\BS=]_#C22=9);27'X^''=:[^VW[&1_DNW^F:?JBOYHOZM.+ M=%5:5W34M\WNF/='3O=W426T=6/I.,DH>5K;@V_1-G:4V5%\)V#6VRZ MPMXO8.PP[D#`0QR@B]0\5T#'3.`YU,;+LYEKW;%.I)57(Z^%FV,ZRKUE^I)5 M7+\?C6J67^6"V,`H(@'Q$`_B/'P^/],`@+>6](K3D9%,6L6^ONS[V^7A=3ZE MKJS0EIOT^DF599%`SDY6T+5H-`P.9J;=^+&*94K$*6_5E/Z8<_'^):VD=%35=G97=.Z)ICL#L+;XW]-EIV/15+4]< MU518KY#5>HF#T`6AZ='+B0SIXJ`2,^\3^:>']$44,6,?VYN_=?5DRX_TK^E> M"=7\618>$[NYO2':E0V\?Z M@7T\E8:H]OX2)9L=OZCE'(Q.I>[6MHDPJ'UWL]%(2M8C9#)J4Y:W:BE!TSJC?GNX8%S'NK,[9Z+E:RBEI+ MG7Q?'GO]5*Y>])>\6J>\6L7MUH;:9IEZI4TM2-WZ.O;<8?:NB]G1I?":H5^K MRQ4G35RV7(%F+-L*Y!)75] M4:[&9@J?E$0#UX'Q`1X`1#D.!$`'@.0RW&KCU/0NP]:JMB#-Y[VK^EH.*,M' M2-QOMQD%:YJ_5E8.D>X[)MQFQG"+>.BV"0?,2LLZ%./B&)3N'"A0*4 MIX97XQ?3O.7TKF_T\RGD9MFRG&/JO\(\WY\N;_T+:TCH]:K2\]MO9KX+;OS8 MS)`MJL2ZA'T92*V*HOH[46M.6Z!(K7E555\!4*FFXG'I#/W@G5.0B6MBP[NNN4^/]/@O!;>)%AX3M2>5??5F2UK_377ICX1V3XTJ9,D(!`X#[^?AQ]@!_ MXRSX\7N=%ZZ\>)SP!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P M!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`& M`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`<3^7'Y0Y'D/3D`] M/Y^F9C2NIE*+TEL<%`,)?0`Y_'CX#CIA)^M)HS"B;ZMC4?W3Z,[-/M!GWTZ# MR\+K3O!2X9O%VJMS*AF&J.X>N(OA9;3N\6C(Q4OUCV4Q"NV8"B]AG8D`QC-^ M0)SLW!N>[]UANEV/\JT4OGI7ST?@]3S_`''#O8]__(X+?O-ZPT5>>^E?_JVT M>K]O1WU5=2[[U.F_JM+MK+M;'6I?4]PZ3SGM1>[:1NU@@9:5JUH;.DTVT508 MU),\@K<%2A"_HP`Y*8RAR-S1K/Z_[5Y.&76CAOKPU2HTU1UKIL]3$.^)VHVH MQIG5I*%'N^3HE1[UKIL]3+C1^B9FLS4IN+(:KU)'/0,XAJ1%+B4SETK_`/8S[THO'QN?90;V,>U/J_P`N7ZG0 ML8<(R^XGKD26KW2\$90`4``HG'H'QRXJTUW+YRP!@#`&`,`8 M`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@# M`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,` M8`P!@#`&`,`8`P!@#`&`,`8`'X#@'S*>'M_GY\>?7CQY^'K_`'?^,V=:Z$>3 MT=/]S8QFK?\`Q,_Y1;(_:'^'/^7?^/:9_EO]`_;'^:?\9?.2/['_`'M\K_\` MTG[:^>]WY;W_`,O_`.KR_)[64_\`M/N95_\`(X_)?I3]2I;^PZ]*>_QY_P"M M*5_,R@+_`*X^&6V7E2GIV.68,C`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#` M&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8 D`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8!__9 ` end GRAPHIC 4 g793817ex99_38img2.jpg GRAPHIC begin 644 g793817ex99_38img2.jpg M_]C_X0`817AI9@``24DJ``@``````````````/_L`!%$=6-K>0`!``0```!D M``#_X01.:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@ M8F5G:6X](N^[OR(@:60](EG)E4WI.5&-Z:V,Y9"(_/B`\ M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)! M9&]B92!835`@0V]R92`U+C4M8S`R,2`W.2XQ-30Y,3$L(#(P,3,O,3`O,CDM M,3$Z-#&UL;G,Z9&,](FAT='`Z+R]P=7)L+F]R M9R]D8R]E;&5M96YT&UL;G,Z&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B('AM<#I##PO'!A8VME="!E;F0](G(B/S[_[0!(4&AO=&]S:&]P(#,N,``X M0DE-!`0```````\<`5H``QLE1QP"```"``(`.$))300E```````0_.$?B=\;@H.J,[1ND9KO735VL(,(1=;O,NML1M9K8Q+F")64*>>0G" M&DJPG+B,*SCY)^H9QX#@.`X$:/?GTNUUTK+I&K*W3IGL#VNV]EW&J.N-&E8F M,G"8AA?V)'9&RK/,.MP&JM0UU[./SY^66R,G/U0W\U87E`5Y_+35W=GOQZ@S M/;/L_P!A[M=:7TY3&&*L&N';+5NN-TVQ>:P7D+2^HJZ\0/3[GKZATRP,E3%F M'`0]+'MB.-K4V1EY071N!'#:O5/J-!=P:1T;K5ELNW-\VS#*Y^+TU77-CP.J M1RI%Z)%)VO.P)3P]2:S(#.()QE+RX]*?F6EA"DY4$CW`>%%`FRVK1[5?S`[)M"YHE8[2VE@ MY^(A+1L^RQP#IKS39LN^R!6ZE$-HP[*S1F4A@,YQC.5O+:9<#''D9WEW#W]Z M>*[*[XU-4])31.U-J56'BJC9EVBG2U+H\W^UAV>*M!+BF945DUHR/(+;RD=T MB.=<0E"<_%(;A=T]<=JUC;5R:FMTW5"7#(R,O=3_`!%3 M4.V8IIM@]MEHYEQHD=3HI#3B5M.+3GZ\#3OOCZ!6#3-LKG4/J#2XKL)Z&;B@ MBY+7&HW9+\:G:EJ/UP*5OCL5."Y<72=55U]Y*FT+Q@Z:(^(PB,Y7E:0KM]DN MN&S$W@KRRT#?[7O3TR]%ZK2;=ZX=X)EI=@#Z]==%'*=E*Q4U".Q<7KZB2;KQ M,/#58?(^2HIIA:FU/DM+;"V7U#ZK:9Z']9=;=<=0`"5[7&HZD*`_+G_AA&3Q MX0+:[)>[8:G#([DW8"V'##7U9PVC*OBGXM(0E(5M?4CVGONS3)+K5T)L,I`5 M&UW"W]7KKJ@E#)>9-$3#&J>D[$T"2\K+X[47C"G<& MM!)_XQ>8T/T5U$O95XI@-2[([BJL+'7>L`RZ[-':IIT9+2\]#ZUC+2=DF:M$ MV9*3+LO:)HTA\N8G7\_-:FA1\\":_@.`X#@.`X#@.`X#@.`X#@.`X$!7OWW+ MG=*=:XCJQIV9K[W8+N283JT&L_G5XF[#:CGD+KE[FJK5IV4B&967L9,J-7(Y M?WTK:-E,O,(><&RC`=E7[9H/P(\UM4:[L+F;EO>UI'@J'K*+D#I_9'9WMI?F M`V!:A`.R1IL_+1S$Z2#%*DRGE-14"&QEQ:?BTVH*XW=C1?9/;O=35N@]I2L9 M>_3'T8:AD=DXJGRUFL])\[^C,Q-1F1M/Z)^U+C%-ST2B.S.VRPX>^"F@TXPS MD:0RLD+`OLCM.D>;GE*+U'ZPUU$5M#L5'Q72WJIKJL!QG[U/VO9:405IGE!* M#4R>9F(E3"Y,U3:7'9*00XIQ+SR59#7?4U@<\C>M'6?QRZ"4V-W7Z3[*K\)/ M[/F&(&5G-:=?YK9N6W[MV=[(240TZZ!3J\^M;5?BWG&7Y8:/'1C#;/TPX&4= MPM:'_K_=0).Z5.&M/:;T0[-&'5&'V?8PPK5OKLEO*8%"4Z=)F2IJY>/U-2#7 M`W6*['NN"B#-BC-M./N_>R&TOE'YX5[SNTGLSL;V+G,63N-V"59-V=PMXV8Y MJ1D@L&N.VTBA,2("?P_X;KH=I>6D,-J1@C+WV<_8^RV@(H.\WIX?WCH.VYZ` MM%TZV>1&HIHK7.W.RM7E((3>'=+<1),2;2-$]80W))V($H5Z%?2P9,R"\C_; M??0>T/\`C.#Y#8_PXZ,SUZ:I_H=V0ID]44P\&53?/'KK9!)"!BNK/77\*0K< M;,B4<]MU^*OE^J+C#)!I!I[YP^%G+7ATU*!PL\\!P'`4P*AQ:5$/89;4O*48RKXISGZ?3&>!R>` MX'4S\[$5>"FK-/G,QD#78F1G9N2(PO+$?$1`;TA)'/8:0XYED0,=;BOBE2OH MG/TQG/`IP:1V9KSN_P"B_9GV1[0F5)CH3T$U6Y&Z`;L!R7B'$N`QEWU]92*L M8:3#V"7L,8X[:HL)YD&3CIZ6C&$X=?1]&PV4H5BAD5[>?]B+T8HP0#E^FC9EKA.P,0HXZ$@S"VHYBLZGI'T7'U>`%;&89' M2UC[:B',YX$1/G!`67T@[,S_`+L]U1'J%UIU=5[4%T%H>R[4T/4M7UJ-FY2, MM.\VH=S$?&1+SL'!8PF6-_SGF&D+PTTV$&M8>HL6\-B^WNPK<4`5<-">&?74 MFSR^Y=O/S%GU=?N]5CH`AIST/3Y2,5%6NLZ`IDM'I-D"&G!GI3\;#:UX<7AD M<,.]$]1M>N7:77FY7=?U[5?E!Y\#V"B=9>KXC'P,ES.QV++$D1- M^5`Q#`TE(/BM_&.G5)"P241B2(<"WTA"6TI0A*4(0G"$(1C"4H2G&,)2E.,8 MPE*<8^F,8_3&.!]N`X#@.`X#@.`X&L>T^Z74G214O';5[':=I,Q`PS]@EJ]+ MWR`_DP<0,20$X8JLB&$S[F%'"N,-H0,IQTA&6D)4Y_QX$4=P_L']:YRU%:\Z MCZ2[%]R;ZH8W,0'JS7$\#7#RF9\2M@$$3,C&/R@=;DI,O"?W),ES4`L#,+>>Y-N*LP,L4.^_\`EC`Q6OCMQ"7LJRG/S#)Z//'TCWA8"K/V9]7MPZQ@2;TJVP>I.F=4J. MJVJC5I&)<2;K0C:LC$&35P$CI=Y&6)(Z*6]EH9/Q0A3KN;18)1%6N^0["6X$2"(PQ' MO.8_&9:;2EO`2.\!P*YW]C7LIL:%ZPU7HAUHE#6NTW>JVUW6%93!SYE?EZWK MDRS10-OG7)&.<9(#&G?OXC<_-;;+@"CU*5C#.?J&DW4KI)J+O#L[7W4K6M:R M?Y)>==I!LFT+0.>:96/0[O\`-1ZT6NR"7$)`"KIK/54\WE$FG]`33D(9;1AI M*,,AFSLO73O:3U!A.GL!(P>?/_S0LD'<^RDM79>5"LMS[)K96[5]9QJ1,8A' M(*.CP7XHS[F'/H"]+I1]%J85P,9?V1O0,R+C:GY1=<9I<7L#:E=A;=V<)@RD MQRJCUD,+:JX.LX?,:M^;(M^V9:0#"'BP!ORG0'&T_-MDE;B`E(\>/,9KI!JB M$V3MIYVP=H[UJVF4&>64#70H[2VIZP5*3M.Z_4@:MC-1S<14Y"?)>DC<+>?D MY%Q2ENK;98^@1\]Y[-,^R_HM%^7^O)F2_P!`>I#3FP_2384,`T/&6793+)R: M)U^C[;(B.,!'")2X04Z-A>&W,/O)<0_'MYR'H]T1\S[)W^$Z"=-KZ#K/R1Z] M,QE6[9[_L'ICPOZ*?EU7K5IZ7B9_OG>],2,:[4]6Z^AT''A:.G6W`).,)=L M+GWTEB/ON..SA06'6\Y'*RD+-^D]-:ZZ\:DUWH[4M>'JVMM65*&I5.@AU*<_ M!A(,-L,7\DE?^8Z0)^WETDEW*G22'%NN9RM:LY#'/:'N!UTZ;4%6Q>Q&S82A M0S[_`.!`13V7I.WW.<<9(=#KE(I\6V78;3/2&1E):8$'<_Y8^J\H3C*L!5]V MC[Q>A^Z=^Z`TMU)ZP5K2\EV8N`SF@]?;[B7)G>MTU;%1%:G9_9FUZV#86(+2 MM)GH:6,-ALEYR6Z("IUQQ.%-)>"XNCY_!'W/I\_BGY_'_P"OS^F/E]/_`(^O M`^W`T/J+T#Z;1,A)]@^T&L*>3')QAVN1\S_+K:HEQ)OXH>:S46IN6$ M>,?`6RVLEMAG[^4(6XG*T_4(W8[U_P"WG;<\]K]>8+-C*J3&YNP4B+K MVAQAX?[HZ5*FPZY&)27#?B!(2TZ-,/O8.=2RX/\`;SE[`?"/,;TE[3ACD=Y_ M1:T5*M6JOFB7O2_6!N;I<>-^=:V9MJ`B+E!R]28#&9K_`,HTDG()Y>5--.,D MXQA>70V9U3X5><^MVX!=BU3-;TDJY&FPX4IO>V2%YP9&&3,?84C3\`,B#J-F M>$FXQHQHF1CB2L&?,A3BGG%+R$K]5I=.HL2-`TBIUJG00274APM5@HNO1(B7 MGED/)&CH@4,-A+I#BEJPE&/DO.59_7/UX'I>`X#@.!Q)`\2+`-DSWT#`QPA) MYI+F?HV.(&RL@E]S/_HAIEM2LY_]L<#^>V)N^S^IWI-MC9&K^-CL=2 M^IUJE`:JW)==^K3-?E7]U[\:JR;`;8&8M.K0Y04=:/VEQZ=MJ:A9+8'[2`RB0LTO7W M)PBPRCHPRU.&K1]49RZE"@_'2VO]9?UWO(N\;#V/82=T[*J\,[L/9MI?PB$L M6\-Z7#(\?6:5%D2&234`"G$L1@&2_?[[<]FYNVGAC89J&A"-EQ\'.U6?O\9%$!K*;IVMH:<55*F@4K$4=@%^4 MPQEW\1_@30>T7?.R]'.I1"M/PAMS[+[_`+97M!Z$IT!A!EH;MVS3D59-WBXG M.4MF+IV9%+PJ27!@GY18H[KZ,/?J%>_5NB;Q<*]5O";JC/VJJ7KTQ,`#+9%4^'.-H="_*:94<]@)@/1'L'J MWQ9\^==]6NF%9JE7W9?X$[4G5G6\4$>F7D)Y$<.-;-HKCH",E96P6822EQGU M.K0X\;,R#*EY6VEWXAN'Y,>?\)Y^]7(R`G2RK%OW;:A=I=E=CV!YLNS638>5*Q>N6Y=Z*"(6O*GT-.$K_P`C[F>!JIW?]IVJKLEOIYYH:\AN M\W>"5LH%.FJY6I0D_5/7T@X]L4NU[RL4']/PX2%&0^M](Q*$,/(0V0\TI:4* M#3/L?HC4WG34Q/2'TIO%0[P^FUNEH2@=?*_?95UO2>LKK.V`'%7KW7G6!$.] M*`5^@E.X./ET1[\T9C.66L-DD-?<#=OQ4\]-CZ.I]F[M=T9"D?K5WSC`)KO3VY=ZE:TE(F1+&Z_P#5%3T! M=$.3Q$D*Y7]H608\Z%D0XR!>2AIIJ0E/DX]\G58<9Q\@WKZO^-G0#JDZB4IN MFF[_`&W")5#MUW5*/[/G'433^'C\(`G&\5,)3C;3+.%C1K+OV!F4Y5GX8SP) M0AQV!&&AA6&1AF&TM,#CMH989:1CXH;::;2EMMM"CR]A`V]VX1-:]3(TMD"1M5"U,J-);OU]:B32Q<%! MN(<:C%XQE2TAE&$)2I(CGT#%_A'TBI73#JF9WT[)&PU=MMZT['2\):[]'P<& M7I#K-$`DV\AM\@<-D>JLW^0?=L4B,P^0AL+(`ZG7%,*QP,,>?;EN]C?6'97I MIL"/>?Z6](4':D\]HHP'[,5<;39PVBK!NI&%IRDZ2Q%NJ)PYGZ/A/&B"N80X M$XC@83[LS,C[N>LVO.BVGY^S@]/>BDQ:Y;LMLN%P`74;+>Q5M0FP:D/D4]!R M)U0K@E=KTDEQO+#IO>;OS9.TNGJR8?MG=.)'J M!XY`G3>1&]5ZYK<^D3LUW#V36V8V/@@N1G9DTM^8LLQE)1N M082+0XY\,+;:8:P\\O"PK_\`5KM#I.Y=A=E>[_II?*_HW7LA^]T#SYZ\;`': MD]FLUJEYE::19J51&SCK%,V"1-:.;"6/"@DN2TN2MYS#8XB\!LS*7KTR]T5- MU;7^O]G>;/G%+2I`MMV%L%_-:R\.3'$,U"OQI#BX\2:PX^IM+S@H(F M,L.NNR25?8P$RVH>O_1CQ^ZL6^4D8?\`XM_D/)9%81A24<"&'SRT7?\`V,[)Q_KMW!K$M%]= MH,A?^@&A;.R$/F+JU>V$]*UR^3S$6;A1F,%UIHXE):'@[`64.]]M+,:+E06# MNS/=7K'U!J\I9]][;JU.I4",43:;(>2Z\A#30 MHR_DI7_G"<*5@(C3O9K?G:N-&8\L>B^UM\05EBP?V+L-N>+D=2:FBI.4+(`P M\_7K$Q"S4O'13@A"GB5'!LI6QA/T7AQOYAV%:\C>PO;-P>S^L_:&0WE&/G2\ MLCK9JI#U2T]%(GH-F#(1%?TAJ2@ZPC?VZ*B2A'2/6_6-]J-K&E;)<)(5 M,)UDU'_+:F!2&JG%%1\=),=@MMA.RT;/1+^"L1;QPSSQ8*UIP&_']FW?78$@ MOI+Y;=?FZA`P'H!/S5&L[LHT2.F9;K4Q3X>E:V)*#E(?%2D MAC8;;0MM3C3@>K[_`/8>)\7N@/7SRZZ1)BQ^SNP=/R\'253=BP$P%'?G3>RKWM.QKC*H`TIE_$F;@A+6&A/MJ"5CQ]\X*YYP]5HBF'+;(]H-^@P-E]:0 MR`T$Q^FJY(0+:HL&'A#2'291$9D:+-F'776!V64LMI#R/MSY\]U_1ZN=>M&= M=]T:SU3HD>]2-L[!HO,/.'2#\A7QA2-:V"*37Y0`^R8KDJZ00U"K6."0>VP\ M4]EMI+>0\[TE_KV]4^N]L@-Y]EYF3[O=HH.(HD="[,V_#10U.UO_`-=MQG\5 M;U!K4!+D53_V5V+:^T4Z\46Y\6>%!#9EY"O1Z'3IHV,''?2)B2D M31A\GE*:8;4]G.`FLCX^/B00XN*!#C(R.&9"CXZ/&9"!!#&;2T.(&(,AL<89 MAI&$H;0E*4IQC&,8QP.9P'`;BH:!HJW0EE+^TE!,FSA+B7,HQD M,R^$_0^(Z4](Z:?+0D>'MO>@,'L>\%JJ4=6YVOUMV`C([7&L"7V'BY,Z,H]5 M$:RG);V7,G&%.9;;ROX)"6BSZIUC=;33+Q<->TNTW+7+\@50;38:S#S$_2R9 M5`[P'JGI#TGV)O"]R<-H M37<97J5UU_##53&KM!RDE(Q-F>DGGGOG"8*E%'OQ^1,K!,.3 MDA(Y"A$-N%)8=R,V\O*&7",-JRRAU:<*4AM3GTPK.,9SC'`K9>6/E)O2.[-; MO]'/22$I1'9O9NP[;(TW6$)+$W"MU%$9;IIFC;*E"2#2H+^5URC/-0=:8"92 MS&0J$DKQB1?<6V%E/@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@4W'^SWO\` M[8U^NS6X7KUTU*32Y2D2<=79ROKUSJF>K4AL>.DZ[/"C+AD;_P!XQL2"X6/F M0?S#Q#J%8:^3*DA>+2G"<82G&$I3C"4I3C&,)QC'TQC&,?IC&,<#YX#@.`X# M@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@0+^/O_P"8G^POIA_I-_,/]@O]GK#_ M`+4_]F?D?RC]V_=)3\#^#_D_I_U+_)?W;\+X?YOR_N?D?I^/P)Z.`X#@.`X# :@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@?_]D_ ` end